11 Analysts Have This to Say About Abbott Laboratories
Latest Ratings for ABT
DateFirmActionFromTo Jan 2022Morgan StanleyMaintainsOverweight Jan 2022Raymond JamesMaintainsOutperform Jan 2022Morgan StanleyMaintainsOverweight
View…
113,080€
3,10%
Echtzeit-Aktienkurs Abbott Laboratories
Bid:
Ask:
Nachrichten zur Abbott Laboratories Aktie
Form 8-K ABBOTT LABORATORIES For: Dec 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abbott Labs boosts dividend by more than 8%
Abbott Laboratories said Friday morning that it would be raising its dividend to 51 cents a share. The increase…
Abbott Laboratories raises quarterly dividend by 8.5% to $0.51/share
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nerve repair and regeneration market 2023-2027: Growth opportunities led by Abbott Laboratories and ALEVA NEUROTHERAPEUTICS SA - Technavio
NEW YORK, Dec. 9, 2022 /PRNewswire/ -- The nerve repair and regeneration market size is estimated to increase by USD…
Clinical Chemistry Global Market Report 2022: Ukraine-Russia War Impact
NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Major players in the clinical chemistry market are Abbott Laboratories, F. Hoffmann-La Roche…
Medical diagnostics market: Growth Opportunities led by 3M Co. and Abbott Laboratories - Technavio
NEW YORK, Dec. 6, 2022 /PRNewswire/ -- The medical diagnostics market size is forecast to grow by USD 74.58 billion…
HIV treatment drugs market in Africa: Growth Opportunities led by Abbott Laboratories and AbbVie Inc. - Technavio
NEW YORK, Dec. 5, 2022 /PRNewswire/ -- The HIV treatment drugs market size in Africa is forecast to grow by…
In-vitro diagnostics instruments market: Growth Opportunities led by Abbott Laboratories and Beijing Leadman Biochemistry Technology Co. Ltd. - Technavio
NEW YORK, Nov. 30, 2022 /PRNewswire/ -- The in-vitro diagnostics instruments market size is estimated to grow by USD 48.3…
NOTICE For Investors In ABT: Lawsuit against Abbott Laboratories announced by Shareholders Foundation
San Diego, California--(Newsfile Corp. - November 29, 2022) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for…
Multiple Myeloma Drugs Market: Growth Opportunities led by Abbott Laboratories and AbbVie Inc. - Technavio
NEW YORK, Nov. 28, 2022 /PRNewswire/ -- The multiple myeloma drugs market size is estimated to grow by USD 6,419.94…
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could…
Worldwide Infectious Disease Diagnostics Industry to 2027 - Featuring Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific and Siemens Healthineers Among Others
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab,…
Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
DUBLIN, Nov. 21, 2022 /PRNewswire/ -- The "Hemoglobinopathies Market By Type, By Therapy, By Distribution Channel: Global Opportunity Analysis and…
2 Reasons to Buy Abbott Labs and 1 Reason to Sell
The healthcare company offers growth and value....…
Better Buy: Johnson & Johnson vs. Abbott Laboratories
These two healthcare giants are among the safest stocks investors can buy right now....…
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock…
Top Research Reports for Abbott Laboratories, ServiceNow & Schlumberger
Todays Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), ServiceNow, Inc. (NOW) and Schlumberger…
Insiderhandel: Aufsichtsrat verkauft Aktien von Abbott Laboratories im Wert von 4.872.933$
Starks, Daniel J. - Aufsichtsrat - Tag der Transaktion: 2022-10-27...…
ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Attention Abbott Laboratories ("Abbott") (NYSE: ABT) shareholders: The Law Offices of Vincent Wong…
ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company")…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott"…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (NYSE: ABT)
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Abbott Laboratories.…
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock…
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Attention Abbott Laboratories ("Abbott") (NYSE: ABT) shareholders: The Law Offices of Vincent Wong…
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
Third-quarter results were less than encouraging on the surface, but what do they say about the road ahead for Abbott…
ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
NEW ORLEANS, Oct. 21, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October…
Form 8-K ABBOTT LABORATORIES For: Oct 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
Breath Analyzer Market Size to Grow by USD 2.58 Bn, Abbott Laboratories and Advanced Safety Devices LLC Among Key Vendors - Technavio
NEW YORK, Oct. 20, 2022 /PRNewswire/ -- The breath analyzer market size is expected to grow by USD 2.58 billion…
ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company")…
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Abbott Laboratories - ABT
CEDARHURST, N.Y., Oct. 19, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to…
Abbott Laboratories predicts COVID-19 will be endemic this winter
Abbott, a major producer of COVID-19 tests, does not think there will be a strong appetite for kits...…
Why Abbott Laboratories Stock Is Slumping Today
A potential drop-off in COVID-19 testing sales is weighing on the healthcare giants shares today....…
Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2022....…
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks…
Übernahmespekulationen treiben Aktien von Biotechfirma Actelion hoch
Zürich/Frankfurt (Reuters) - Wiederaufgeflammte Übernahmespekulationen haben die Aktien der Schweizer Biotechnologiefirma Actelion auf ein Rekordhoch gehoben.
Vertreter von Europas größtem…